PhRMA: Roughly 400 new meds in pipeline for infectious diseases

America's biopharmaceutical research companies this year have 395 new medicines and vaccines in the pipeline to fight infectious diseases. Some of the diseases targeted plague the developing world, while others threaten lives in every country. Six medicines and five vaccines for malaria are currently in development, according to a PhRMA report. Of the 395 medicines and vaccines, 24 are on a fast track--including those for hepatitis C, severe sepsis and pneumonia. PhRMA release | Report

Suggested Articles

Janssen’s BCMA-targeting CAR-T therapy eliminated tumors in 69% of patients with advanced multiple myeloma in a small phase 1 study.

In a study, BMS' CAR-T therapy banished tumors in more than half and shrank tumors in nearly three-quarters of relapsed blood cancer patients.

Novartis unveiled more data showing how its asthma combo QMF149 fared against the standard of care: a combination of the same types of drugs.